Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01190631 · ClinicalTrials.gov registry record · NA
An Assessment of Residual Spherical Aberration, Postoperative Total High Order Aberrations, and Functional Vision Correlation Following Intraocular Lens (IOL) Implantation
A NA study, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT01190631 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 100 participants.
The verdict
NCT01190631, a NA study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this study was to evaluate total residual spherical aberration (TSA) post-IOL implantation, and to determine if an association exists between TSA, postoperative high order aberrations (HOA), and functional vision following IOL implantation in patients grouped by pre-operative corneal spherical aberration (CSA).
Interventions
- DEVICE Acrysof IQ (SN60WF) IOL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2010-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01190631
The ClinicalTrials.gov registry entry for NCT01190631 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Acrysof IQ (SN60WF) IOL is the first listed.
NCT01190631 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01190631 about?
NCT01190631 is a clinical study titled "An Assessment of Residual Spherical Aberration, Postoperative Total High Order Aberrations, and Functional Vision Correlation Following Intraocular Lens (IOL) Implantation". The purpose of this study was to evaluate total residual spherical aberration (TSA) post-IOL implantation, and to determine if an association exists between TSA, postoperative high order aberrations (HOA), and functional vision following IOL implantation in patients grouped by pre-operative corneal ...
What is the current status of trial NCT01190631?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2010-07.
What interventions are being tested in trial NCT01190631?
The interventions under investigation include: Acrysof IQ (SN60WF) IOL (DEVICE).
Who is sponsoring clinical trial NCT01190631?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.